2m 2m 2m 2m 2m 2m 2m
Merck (MRK)
NYSE
$140.65-$4.62 (-3.18%)
Price as of Oct 26, 2026 4:54 PM EDT- $358.4BMarket Cap
- 70.92%1-Year Change
- Drug Manufacturers - GeneralIndustry
Merck (MRK)
$140.65-$4.62 (-3.18%)
MRK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $145.27 | ||
Change | -$1.97 (-1.34%) | ||
Open | $145.02 | ||
High | $145.44 | ||
Low | $143.41 | ||
Previous Close | $147.24 | ||
Volume | 8,381,401 | ||
30-Day Average Volume | 9,661,019 | ||
1-Week Change | -0.47% | ||
1-Month Change | -1.90% | ||
1-Year Change | 70.92% | ||
3-Year Change | 54.03% | ||
5-Year Change | 108.60% | ||
Fundamentals | |||
Shares Outstanding | 2.5B | ||
Total Assets | $129.8B | ||
Market Cap | $358.4B | ||
Enterprise Value | $405.5B | ||
Period: QTR TTM FY | |||
Revenue | $16.6B | ||
Net Income | -$1.3B | ||
Free Cash Flow | $4.5B | ||
EBIT | -$681.0M | ||
EBITDA | -$82.0M | ||
Net Working Capital | $8.9B | ||
EPS | -$0.54 | ||
Enterprise Value/EBITDA | -4,945 | ||
Enterprise Value/Revenue | 24 | ||
P/B | 9 | ||
P/E | -269 | ||
PEG | -4 | ||
Price/Free Cash Flow | 80 | ||
Price/Operating Cash Flow | 67 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.34% | ||
Trailing Annual Dividend Yield | 2.34% | ||
Ex-Dividend Date | 09/15/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield